A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint based on progenitor insertion release 3 sequence coordinate 3R:10557267 , per R. Hoskins (Gene Disruption Project) personal communication, mapped forward to release 5.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3R)Exel6172.
Inferred to overlap with: Df(3R)Exel8160.
The presence of P+PBac{XP5.RB3}BSC635 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer 5'-GCTTCTAAACGCTTACGCATAAACGATG-3' for the RB3' plus or RB3' minus primer in the Hybrid PCR protocol in FBrf0174229.
The cytological breakpoints of Df(3R)BSC635 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d04917 and PBac{RB}CG6687e04451 insertion sites are 88D2;88E3.